Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma-Reference-Cited by-同舟云学术

Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma

Published:2020-03 Issue: Volume:472 Page:29-39
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Vanbervliet-Defrance Béatrice,Delaunay Tiphaine,Daunizeau Thomas,Kepenekian Vahan,Glehen Olivier,Weber Kathrin,Estornes Yann,Ziverec Audrey,Djemal Leila,Delphin Marion,Lantuéjoul Sylvie,Passot Guillaume,Grégoire Marc,Micheau Olivier,Blanquart Christophe^ORCID,Renno Toufic,Fonteneau Jean-François^ORCID,Lebecque Serge,Mahtouk Karène

Funder

Ligue Contre le Cancer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. TLR3 immunity to infection in mice and humans;Zhang;Curr. Opin. Immunol.,2013

2. Trial Watch: Toll-like receptor agonists for cancer therapy;Vacchelli;OncoImmunology,2013

3. Toll-like receptors and cancer;Rakoff-Nahoum;Nat. Rev. Cancer,2009

4. TLR3 can directly trigger apoptosis in human cancer cells;Salaun;J. Immunol.,2006

5. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma;Morikawa;Clin. Cancer Res.,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas;Seminars in Radiation Oncology;2024-04

2. RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans;Biomedicine & Pharmacotherapy;2024-04

3. Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma;Pathology - Research and Practice;2023-12

4. TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization;Microbial Cell;2023-06-05

5. Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy;Cancers;2023-05-29